Pacific Wealth Strategies Group Inc. increased its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 14.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,795 shares of the company’s stock after acquiring an additional 1,393 shares during […]
Hancock Whitney Corp raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,097 shares of the company’s stock after buying an additional 1,126 shares during the period. Hancock […]
Sabal Trust CO increased its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 1,997.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 172,038 shares of the company’s stock after buying an additional 163,837 shares during the quarter. Sabal Trust […]
Gibraltar Capital Management Inc. decreased its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 23.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,546 shares of the company’s stock after selling 2,059 shares during the quarter. Gibraltar […]
G&S Capital LLC increased its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 5.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,121 shares of the company’s stock after acquiring an additional 219 shares during the quarter. G&S Capital LLC’s holdings in AbbVie were worth $558,000 at the end of the most […]